Obesity in older adults is a clinical problem about mobility, independence, and quality of life, and the number on the scale is the least interesting part of it. The problem is growing as the population ages. In the NHANES data, 38.9% of adults 60 and over meet criteria for obesity (Emmerich SD, NCHS 2024).

Between 2010 and 2050 the U.S. population over 65 will nearly double, from 40 million to more than 80 million (U.S. Census Bureau). Aging brings multimorbidity, frailty, and loss of independence with it, and excess adiposity adds a layer on top. Older adults with obesity are more likely to experience disability, reduced gait speed, and earlier institutionalization (Batsis JA, Eur J Intern Med 2014; Elkins JS, Obesity 2006). Body composition also shifts with age, with sarcopenia and visceral adiposity together making BMI a much less trustworthy measure than it looks (Batsis JA, Int J Obes 2016).

So the question is not really whether weight loss is safe in older adults. It is how it gets done. Intentional, structured weight loss helps when it is handled carefully. Randomized trials show that combining diet with exercise improves physical performance even when the weight loss itself is modest (Villareal DT, NEJM 2011; Batsis JA, J Am Geriatr Soc 2016). The danger sits with weight loss that is unintentional or too aggressive, which costs lean mass and bone density and raises fracture risk (Ensrud KE, J Clin Endocrinol Metab 2005). That is why the intervention has to protect muscle: resistance training, and protein intake of at least 1.0 to 1.2 g/kg/day, with leucine-rich sources where possible (Porter Starr K, J Gerontol Med Sci 2016).

Function is the goal, not the scale. Better mobility, more independence, better quality of life. Which means starting with an assessment of baseline function and cognition before recommending weight loss at all, and factoring in food security, transportation, and whether the patient is also caring for someone else. Physical therapists, dietitians, and care managers earn their place in this (Batsis JA, JAMDA 2011).

Medications are an option and they need care here. GLP-1 receptor agonists like semaglutide and liraglutide, and combinations like bupropion/naltrexone, are promising, but older adults have been poorly represented in the trials (Hollander P, Diabetes Care 2013; Grunvald E, Gastroenterology 2022). In practice hypotension, hypoglycemia, GI intolerance, and lean mass loss all carry more weight in a frail patient than they would in a younger one (Volpe S, Nutrients 2023; Batsis JA, Nat Rev Endocrinol 2018). I go slower on titration with these patients than the labeling suggests, and I ask about falls before I ask about weight.

What works is tailored and multidisciplinary. DASH or Mediterranean patterns are reasonable starting points. Activity should be gradual, supervised, and matched to ability, along the lines of the LIFE trial (Pahor M, JAMA 2015). Behavioral support delivered through community programs or telemedicine works in this population, which matters given how much harder it is for older patients to get to an office (Alberts SM, Gerontologist 2021; Batsis JA, BMC Geriatrics 2021). And sarcopenia, osteoporosis, and medication side effects all need watching throughout.

Treating obesity in older adults means preserving mobility, strength, and vitality rather than chasing an ideal weight. Done carefully, it buys people independence and dignity, which is what they came in for.

Scott Rennie, D.O.

Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.